Katherine A. Scilla - Concepedia

Author

Katherine A. Scilla

Also Known As

K. Scilla, K.A. Scilla, Katherine A Scilla, Katherine A. Scilla, Katherine Ann Scilla, Katherine Scilla, Nagaprasad Nagajothi

Publications

858

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Johns Hopkins Medicine Fox Chase Cancer Center Instituto Português de Oncologia Francisco Gentil

About

Katherine A. Scilla is an author at University of Maryland, Baltimore specializing in oncology, medicine, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	151
2	Immunology	2	2	26
3	Health Sciences	1	1	11
4	Allergy	1	1	11
5	Cell Biology	1	1	13

Katherine A. Scilla

Publications

254

Citations

H-Index

Page 1

	Year	Citations
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy Katherine A. Scilla, Søren M. Bentzen, Vincent K. Lam, The Oncologist	2017	103
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC) Vincent K. Lam, Søren M. Bentzen, Pranshu Mohindra, Lung Cancer ObesityMedicineLong-term Improved SurvivalObesity ManagementCancer Treatment	2016	90
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection Katherine A. Scilla, Dan P. Zandberg, Søren M. Bentzen, Lung Cancer Human Immunodeficiency VirusMedicineHuman RetrovirusImmunologyB7-h3 Expression	2018	15
NTRK and NRG1 gene fusions in advanced non-small cell lung cancer (NSCLC) Alessandro Russo, Ana Rita Lopes, Katherine A. Scilla, Precision Cancer Medicine Ntrk-rearranged NsclcPathologyCancer BiologyTumor BiologyCancer Cell Biology	2020	13
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non–small-cell Lung Cancer Treated With Curative Intent Stephanie R. Rice, Melissa A.L. Vyfhuis, Katherine A. Scilla, Clinical Lung Cancer Prognostic EvaluationCurative IntentOverall SurvivalMedicineCancer Management	2019	11
Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report Ana Rita Lopes, Alessandro Russo, Andrew Y. Li, Translational Lung Cancer Research ImmunologyImmunoeditingPathologyImmunotherapySevere Diabetic Ketoacidosis	2020	11
Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy: Management of C797S Acquired Mutation Alessandro Russo, Katherine A. Scilla, Ranee Mehra, Clinical Lung Cancer OncologyTumor HeterogeneityMedicinePathologyCancer Genomics	2023	11

Page 1